Tag

GDP

Good distribution practice (GDP) and the pharmaceutical supply chain, covered in MPCA's regulatory watch.

Stock Monitoring Tool: draft royal decree approved on 18 July 2026 GDP & Distribution
11 Aug 2026

Stock Monitoring Tool: draft royal decree approved, mandatory reporting is coming

On 18 July 2026 the Council of Ministers approved the draft royal decree introducing the Stock Monitoring Tool....

Read more
Missed CAPA timelines: GDP certificate refused after late corrective actions GDP & Distribution
10 Aug 2026

Missed CAPA timelines: lessons from a recent GDP non-compliance case

A wholesaler was refused a GDP certificate after missing agreed CAPA deadlines. Why execution, not the plan, decides...

Read more
MPCA International - Belgium's Stock Monitoring Tool go-live postponed GDP & Distribution
11 Jun 2026

Stock Monitoring Tool: the 1 July go-live looks set to be postponed

An early heads-up: the FAMHP’s Stock Monitoring Tool, due to go live on 1 July 2026, looks set...

Read more

Need help navigating the Benelux regulatory landscape?

Our team of specialists is ready to support you — from regulatory strategy and pharmacovigilance to market access and quality assurance.

Request a free consultation Our services

Your reference partner for Regulatory Affairs, Pharmacovigilance and Quality Affairs in the Benelux. Active since 1998 from Ghent, Belgium.

Accreditations

QP GMP RP GDP RIP EU QPPV/LCP
Services
Applications
Company
Contact

© 2026 M.P.C.A. International BV  ·  Privacy policy  |  Cookie policy

QP GMP RP GDP RIP EU QPPV/LCP